Skip to main content
logo
Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
169.80
+1.20 (0.71%)
Oct 21, 2026, 3:59 PM HKT

Duality Biotherapeutics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
15,37426,664---
Market Cap Growth
-47.74%----
Enterprise Value
12,30022,676---
Last Close Price
168.60298.20---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
15.7012.94---
PB Ratio
9.119.87---
P/TBV Ratio
9.139.89---
P/FCF Ratio
-130.88---
P/OCF Ratio
-123.14---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
12.5411.00---
EV/FCF Ratio
-111.30---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.260.060.000.00-0.01
Debt / EBITDA Ratio
---0.01-
Debt / FCF Ratio
-0.820.020.01-
Net Debt / Equity Ratio
-1.84-1.330.691.010.49
Net Debt / EBITDA Ratio
1.797.147.63-1.531.01
Net Debt / FCF Ratio
3.20-17.64-4.94-1.401.24
Asset Turnover
0.220.621.081.82-
Quick Ratio
1.853.520.480.500.33
Current Ratio
1.993.650.490.520.33
Return on Equity (ROE)
-65.93%-1282.14%---
Return on Assets (ROA)
-24.30%-9.61%-6.51%46.87%-
Return on Capital Employed (ROCE)
-84.70%-16.20%10.50%-69.40%48.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-10.88%-10.83%---
FCF Yield
-6.30%0.76%---
Buyback Yield / Dilution
-259.84%-714.45%---